AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionFragasso Group Inc.
Latest Disclosed Ownership20,341 shares
Latest Disclosed Value $ 4,204,264
Fragasso Group Inc. reports 1.23% increase in ownership of ABBV / AbbVie Inc.

On April 7, 2026 - Fragasso Group Inc. filed a 13F-HR form disclosing ownership of 20,341 shares of AbbVie Inc. (US:ABBV) valued at $4,423,964 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 20,093 shares of AbbVie Inc.. This represents a change in shares of 1.23% during the quarter. The current value of the position is $4,416,641 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F ABBVIE COM 00287Y109 20,341 248 1.23 4,204 -8.41 0.2534
2026-01-07 2025-12-31 13F ABBVIE COM 00287Y109 20,093 -1,065 -5.03 4,591 -7.24 0.2780
2025-10-06 2025-09-30 13F ABBVIE COM 00287Y109 21,158 -266 -1.24 4,949 24.45 0.3089
2025-07-09 2025-06-30 13F ABBVIE COM 00287Y109 21,424 291 1.38 3,977 -10.19 0.2682
2025-04-09 2025-03-31 13F ABBVIE COM 00287Y109 21,133 8,361 65.46 4,428 95.11 0.3286
2025-01-13 2024-12-31 13F ABBVIE COM 00287Y109 12,772 180 1.43 2,270 -8.73 0.1731
2024-10-07 2024-09-30 13F ABBVIE COM 00287Y109 12,592 409 3.36 2,487 19.00 0.1910
2024-07-09 2024-06-30 13F ABBVIE COM 00287Y109 12,183 229 1.92 2,090 -4.00 0.1722
2024-04-10 2024-03-31 13F ABBVIE COM 00287Y109 11,954 -27 -0.23 2,177 17.24 0.1841
2024-01-08 2023-12-31 13F ABBVIE COM 00287Y109 11,981 -163 -1.34 1,857 2.54 0.1690
2023-12-06 2023-09-30 13F ABBVIE COM 00287Y109 12,144 179 1.50 1,810 12.28 0.1903
2023-07-10 2023-06-30 13F ABBVIE COM 00287Y109 11,965 271 2.32 1,612 -13.47 0.1723
2023-04-13 2023-03-31 13F ABBVIE COM 00287Y109 11,694 32 0.27 1,864 -1.11 0.2123
2023-01-24 2022-12-31 13F/A-1 ABBVIE COM 00287Y109 11,662 30 0.26 1,885 20.69 0.2186
2022-10-13 2022-09-30 13F ABBVIE COM 00287Y109 11,632 56 0.48 1,561 -11.96 0.2212
2022-08-30 2022-06-30 13F ABBVIE COM 00287Y109 11,576 -49 -0.42 1,773 -5.89 0.2390
2022-04-06 2022-03-31 13F ABBVIE COM 00287Y109 11,625 154 1.34 1,884 21.31 0.2221
2022-01-19 2021-12-31 13F ABBVIE COM 00287Y109 11,471 -639 -5.28 1,553 18.91 0.1834
2021-10-08 2021-09-30 13F ABBVIE COM 00287Y109 12,110 645 5.63 1,306 1.16 0.1727
2021-07-19 2021-06-30 13F ABBVIE COM 00287Y109 11,465 23 0.20 1,291 4.28 0.1728
2021-05-27 2021-03-31 13F ABBVIE COM 00287Y109 11,442 103 0.91 1,238 1.89 0.1739
2021-02-04 2020-12-31 13F ABBVIE COM 00287Y109 11,339 62 0.55 1,215 22.98 0.1813
2020-11-05 2020-09-30 13F ABBVIE COM 00287Y109 11,277 69 0.62 988 -5.09 0.1647
2020-08-10 2020-06-30 13F ABBVIE COM 00287Y109 11,208 4,746 73.44 1,041 111.59 0.1771
2020-05-14 2020-03-31 13F ABBVIE COM 00287Y109 6,462 0 0.00 492 -13.99 0.1117
2020-02-13 2019-12-31 13F ABBVIE COM 00287Y109 6,462 135 2.13 572 19.42 0.0962
2019-11-13 2019-09-30 13F ABBVIE COM 00287Y109 6,327 62 0.99 479 5.04 0.0888
2019-08-13 2019-06-30 13F ABBVIE COM 00287Y109 6,265 70 1.13 456 -8.62 0.0902
2019-05-08 2019-03-31 13F ABBVIE COM 00287Y109 6,195 70 1.14 499 -11.68 0.1065
2019-02-12 2018-12-31 13F ABBVIE COM 00287Y109 6,125 -7 -0.11 565 2.91 0.1264
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 6,132 475 8.40 549 4.77 0.1329
2018-08-01 2018-06-30 13F ABBVIE COM 00287Y109 5,657 0 0.00 524 -2.06 0.1350
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 5,657 -74 -1.29 535 -3.43 0.1325
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 5,731 113 2.01 554 11.02 0.1346
2017-11-13 2017-09-30 13F/A-1 ABBVIE COM 00287Y109 5,618 5,618 499 0.1504
2015-01-21 2014-12-31 13F AbbVie COM 00287Y109 0 -5,183 -100.00 0 -100.00
2014-11-03 2014-09-30 13F AbbVie COM 00287Y109 5,183 115 2.27 299 4.55 0.2336
2014-08-15 2014-06-30 13F AbbVie COM 00287Y109 5,068 -46 -0.90 286 8.75 0.2522
2014-08-15 2014-03-31 13F AbbVie COM 00287Y109 5,114 0 0.00 263 -2.59 0.2710
2014-08-15 2013-12-31 13F AbbVie COM 00287Y109 5,114 5,114 270 0.2412
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.